Imagine a world where genetic sequencing is free, like Gmail. That’s where we’re headed. Genetic data is going the way the rest of our data has gone on the web. Companies will mine it, repackage it, and find a way to make money off it.
For eight years, personal genomics company 23andMe has been giving consumers access to their genes. It started off costing $999. Today it’s $99. In 2012, the company allowed consumers to share their data with third-party apps, the way you might link your Facebook profile to your Hulu account.
And this week, what could be seen as another step toward the full webification of our DNA went down, thanks to a new deal between 23andMe and Genentech, one of its early investors.
To start, Genentech will pay to get access to the genetic and health information 23andMe has amassed from more than 10,000 of its customers with Parkinson’s disease, a disorder that…
View original post 1,144 more words